Centure Applications Ltd. (GreenEye Technology)

greeneye.ag

High-Tech Company

TECH VERTICALS

AgriTech, Smart Farming Artificial Intelligence, Climate Tech, Crops, Drones, FoodTech, Machine Learning, Pesticides, Precision Agriculture, UAV

General Data

Sector	Agritech
Company Stage:	Initial Revenues
Established	2015
Number of Employees	50
Employees in Israel	40
Reg. Number:	abCDe

DESCRIPTION

Greeneye is a developer of herbicide technology, designed to automate field scouting. The company's technology utilizes machine learning and artificial intelligence to improves the pest control process in agriculture and transits it from the current practice of broadcast and wasteful spraying of pesticides to precise spraying in real-time, enabling farmers to optimize their herbicide spraying plants with the insight in their field.

TECHNOLOGY

Greeneye's technology allows farmers to go from uniform spraying of pesticides over the entire field to surgical and precise spraying only on the weeds in the field. The company's system interfaces with any existing sprayer, regardless of the model of the sprayer and turns it into a smart machine.

	TARGET MARKETS
	Growers, Farmers.

	BUSINESS MODEL
	B2B2C

COMPETITORS

Bloomfield , Blue River Technology , Bilbery

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Accounting Firm

REMARKS

Date	Remark
17/04/2024	Centure Applications initially developed a mobile application (CNature), designed for the identification of wild plants and animals in real-time. In 2017 the company pivoted and founded GreenEye Technology, pioneering the use of precision spraying technology.
01/04/2022	In April 2022, it announced the commercial launch of its technology in North America, signaling a major milestone in unlocking mainstream adoption of precision spraying by overcoming previous barriers of efficacy, speed of delivery and cost.
28/05/2018	Won first prize of NIS 0.5m at SilicoNegevBGU startup contest.

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	13 Shocken St.
City	Tel Aviv
Country	Israel
Zip	6311720

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Montreal, QC, Canada

City	Montreal, QC
Country	Canada

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: United States

Country	United States

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Nadav Bocher	CEO & Co-Founder
Mr. Alon Klein-Orbach	CTO & Co-Founder
Dr. Itzhak Khait	CPO & Co-Founder
Mr. Guy Molcho	COO & General Manager, Israel
Mr. Guy Zeron	VP, Finance
Mr. Ori Sarfaty	VP, R&D	Emedgene (an Illumina company) (VP, R&D)
Mr. Liron Hillel	VP, Business Operations
Mr. Amir Berger	VP, Engineering	Carestream Health (VP, R&D)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	Managing Partner & Co-Founder, Deep Insight
abC Defghij	Board Member	Managing Partner, Hyperplane
abC Defghij	Board Member	Principal, JVP
abC Defghij	Board Member	General Partner, JVP
abC Defghij	Observer	Managing Director, Syngenta Ventures

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

First Round - Extended

Jan. 15, 2024

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Private Investor	abCDe	Through Waldo Holdings
abC Defghij	Business Development Company	abCDe
abC Defghij	Private Investor	abCDe

First Round - Extended

Jan. 25, 2023

Initial Revenues

abCDe

First Round - Extended

Apr. 01, 2022

Initial Revenues

abCDe

First Round

Dec. 16, 2021

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Traditional Industry	abCDe
abC Defghij	Private Investor	abCDe	Through Waldo Holdings

Seed - Extended

May. 26, 2020

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Angel Club/ Group	abCDe

Seed - Extended

Dec. 01, 2018

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Round co-leader
abC Defghij	Venture Capital Fund	abCDe	Round co-leader
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	General Accelerator	abCDe

Seed - Extended

May. 28, 2018

Seed

abCDe

Seed

Jan. 01, 2015

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

May. 01, 2024

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2021

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2019

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Mar. 27, 2018

R&D

abCDe

Received for its Cnature application prior the foundation of GreenEye

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-National Fund	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Jun. 03, 2020

R&D

Contributor	Type	Amount	Remarks
abC Defghij	Impact Accelerator	abCDe

Last Updated:	abCDe
IVC Number:	abCDe